Insider trades

Robert W. Duggan, CEO of Summit Therapeutics SMMT, has filed 31 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $77.9M. The latest trade was on 06/12.

Robert W. Duggan

Co-CEO
First filing
23/03/08
Trades
96 trades
Buys / sales
31 / 0
12-month net buying
$77.9M
Last trade
06/12

Trading activity

Transactions

Trade type
Open-market buy06/1206/123,810,000 sh$13.12$49,987,200+0.7%
Open-market buy06/0406/04100,000 sh$14.60$1,460,000+0.4%
Open-market buyAmendment05/1105/15660,233 sh$19.69$12,999,987.77+1.4%
Open-market buy05/1105/11660,233 sh$19.69$12,999,987.77+1.4%
Open-market buy25/10/2125/10/2326,680 sh$18.74$499,983.2+53.4%
PLSE
Open-market buy24/09/11–25/09/1025/09/12192,599 sh3 trades$14.48avg.$2,788,624.34+0.4%
SMMT
Open-market buy25/09/10–25/09/1125/09/11338,394 sh2 trades$17.69avg.$5,984,755.92+0.1%
PLSE
Open-market buy24/12/12–24/12/1324/12/17100,660 sh2 trades$17.16avg.$1,727,068.6+0.2%
PLSE
Open-market buy24/12/1124/12/1356,054 sh2 trades$17.35avg.$972,343.96+0.1%
Open-market buy23/12/1223/12/1417,999 sh$9.15$164,690.85+0.0%
Open-market buy23/12/1123/12/1390,118 sh$9.36$843,504.48+0.2%
Open-market buy23/12/0823/12/12116,656 sh$9.54$1,112,898.24+0.3%
Open-market buy23/12/0723/12/1174,852 sh$9.19$687,889.88+0.2%
Open-market buy23/12/0623/12/0882,813 sh$9.06$750,285.78+0.2%
Open-market buy23/12/0523/12/0766,021 sh$9.34$616,636.14+23.1%
Open-market buy23/12/0423/12/0627,000 sh$10.38$280,260+10.4%
Open-market buy23/12/0123/12/0545,600 sh$9.07$413,592+21.4%
Open-market buy23/11/3023/12/04152,944 sh$9.06$1,385,672.64+254.9%
PLSE
Open-market buy23/11/2923/12/01218,600 sh2 trades$9.38avg.$2,049,784No record
Open-market buy23/11/2823/11/30124,397 sh$8.98$1,117,085.06+0.3%